When you linking your Twitter Account Market Wire News Trending Stocks news and your Portfolio Stocks News will automatically tweet from your Twitter account.
Be alerted of any news about your stocks and see what other stocks are trending.
RUBY - Rubius launches early-stage study of lead drug in PKU
Rubius Therapeutics Inc.
Dosing is underway in a Phase 1 clinical trial evaluating Rubius Therapeutics' (RUBY-4.5%) lead candidate RTX-134, an allogeneic off-the-shelf cell therapy, for the potential treatment of phenylketonuria (PKU), a rare inborn error of metabolism characterized by the buildup of the amino acid phenylalanine in the body leading to serious health problems.
More news on: Rubius Therapeutics, Inc., Synlogic, Inc., Homology Medicines, Inc., Healthcare stocks news, Stocks on the move,